Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Pfizer
(NY:
PFE
)
28.71
-0.17 (-0.59%)
Official Closing Price
Updated: 7:00 PM EDT, Aug 15, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Pfizer
< Previous
1
2
...
19
20
21
22
23
24
25
26
27
...
33
34
Next >
Pfizer Announces Positive Top-Line Results for Phase 3 Trial of Etrasimod in Ulcerative Colitis Patients
March 23, 2022
From
Pfizer Inc.
Via
Business Wire
Pfizer Invites Public to View and Listen to Webcast of May 3 Conference Call with Analysts
March 22, 2022
From
Pfizer Inc.
Via
Business Wire
Pfizer to Supply UNICEF up to 4 Million Treatment Courses of Novel COVID-19 Oral Treatment for Low- and Middle-Income Countries
March 22, 2022
From
Pfizer Inc.
Via
Business Wire
Vitiligo Market to Accelerate Substantially During the Forecast Period – DelveInsight | Key Companies – Amgen, Pfizer, Arcutis, Incyte Corp, and Sun Pharma Global FZE, and Others
March 10, 2022
Continue reading "Vitiligo Market to Accelerate Substantially During the Forecast Period – DelveInsight | Key Companies – Amgen, Pfizer, Arcutis, Incyte Corp, and Sun Pharma Global FZE, and Others"
Via
Get News
Acurx Pharmaceuticals Ibezapolstat Targets Front-Line Opportunity After Pfizer Fails To Reach CDI Trial Primary Endpoint (NASDAQ: ACXP)
March 07, 2022
Via
AB Newswire
NetworkNewsAudio – Flora Growth Corp. (NASDAQ: FLGC) Makes Mark in ‘Whirlwind’ of M&A Activity
March 04, 2022
Via
Investor Brand Network
Exposures
COVID-19
iShowcaseTV offers diverse original content in different genres
March 02, 2022
Via
AB Newswire
Renewable Energy Investment Market Size, Share, Trends, Industry Growth, and Forecast 2028 Top Key Players Spectrum, Roche, Pfizer, Novartis, Merck, Bayer, Healthcare Amgen
March 01, 2022
Renewable Energy Investment Market Size, Share, Growth, Industry Trends, Business Scope, Global Providers, COVID-19 Impact and Forecast 2028
Via
SBWire
Exposures
COVID-19
2022 Primed after 2021’s Record M&A Deals
March 01, 2022
Via
Investor Brand Network
Exposures
COVID-19
2022 Primed after 2021’s Record M&A Deals
March 01, 2022
Via
Investor Brand Network
Exposures
COVID-19
2022 Primed after 2021’s Record M&A Deals
March 01, 2022
NetworkNewsWire Editorial Coverage New York, NY – March 1, 2022 – Last year was a monumental year for merger and acquisition activity. Records worldwide weren’t just broken, they were smashed by M&A...
Via
FinancialNewsMedia
Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
February 28, 2022
From
Pfizer Inc.
Via
Business Wire
mRNA Vaccines in Medical Engineering Cancer Treatment
February 24, 2022
New York, NY -- (SBWIRE) -- 02/24/2022 -- The same mRNA technology used in Pfizer-BioNTech's and Moderna's Covid vaccines is being trialed as a unique new medical engineering cancer treatment. The way...
Via
SBWire
Exposures
COVID-19
Pfizer Invests $68.5 Million in New Pharma R&D Facility
February 24, 2022
New York, NY -- (SBWIRE) -- 02/24/2022 -- Gene therapy is a vital field and one generating a wealth of R&D jobs in pharma today. Companies such as Pfizer are keen to capitalize on progress, as this...
Via
SBWire
Pfizer Invites Public to View and Listen to Webcast of Pfizer Keynote Presentation at Healthcare Conference
February 22, 2022
From
Pfizer Inc.
Via
Business Wire
U C, Inc., SMMR, Appoints New Board Member and CEO
February 21, 2022
U C, Inc., formerly named Symmetry Technologies, Inc. (OTC: SMMR), (the "Company"), announced today that, effective Feb. 14, 2022, it has appointed David Reckles as a new member to its Board of...
Via
Newswire.com
Topics
Stocks
Exposures
US Equities
Pfizer and OPKO’s Once-Weekly NGENLA™ (somatrogon) Injection Receives Marketing Authorization in European Union for Treatment of Pediatric Growth Hormone Deficiency
February 15, 2022
From
Pfizer Inc.
Via
Business Wire
European Medicines Agency Approves Pfizer’s 20-Valent Pneumococcal Conjugate Vaccine Against Invasive Pneumococcal Disease and Pneumonia in Adults
February 15, 2022
From
Pfizer Inc.
Via
Business Wire
Pfizer and BioNTech Provide Update on Rolling Submission for Emergency Use Authorization of Their COVID-19 Vaccine in Children 6 Months Through 4 Years of Age
February 11, 2022
From
Pfizer Inc.
Via
Business Wire
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
February 09, 2022
From
Pfizer Inc.
Via
Business Wire
Pfizer Reports Fourth-Quarter and Full-Year 2021 Results
February 08, 2022
From
Pfizer Inc.
Via
Business Wire
Pfizer and BioNTech Initiate Rolling Submission for Emergency Use Authorization of Their COVID-19 Vaccine in Children 6 Months Through 4 Years of Age Following Request From U.S. FDA
February 01, 2022
From
Pfizer Inc.
Via
Business Wire
Pfizer Announces New Chief Development Officer
February 01, 2022
From
Pfizer Inc.
Via
Business Wire
Pfizer and AWS Working Together to Speed Up Clinical Operations Trials
January 28, 2022
New York, NY -- (SBWIRE) -- 01/28/2022 -- Technology is vital to optimizing the process of clinical operations trials in the near future - and this has been brought one step closer by the news that...
Via
SBWire
European Commission Approves LORVIQUA® (lorlatinib) as a First-Line Treatment for ALK-Positive Advanced Lung Cancer
January 28, 2022
From
Pfizer Inc.
Via
Business Wire
Pfizer Receives CHMP Positive Opinion for Novel COVID-19 Oral Treatment
January 27, 2022
From
Pfizer Inc.
Via
Business Wire
R&D Spending Increases Exponentially for Higher Standard of Breast Cancer Drug Treatments
January 27, 2022
Palm Beach, FL – January 27, 2022 – FinancialNewsMedia.com News Commentary – According to International Agency for Research on Cancer (IARC) published by the World Health Organization (WHO) in 2018,...
Via
FinancialNewsMedia
Topics
Death
Intellectual Property
Exposures
Death
Intellectual Property
Pfizer and BioNTech Initiate Study to Evaluate Omicron-Based COVID-19 Vaccine in Adults 18 to 55 Years of Age
January 25, 2022
From
Pfizer Inc.
Via
Business Wire
Dietary Supplements Market Growing at a CAGR of 7.0% | Key Players are Amway, Herbalife Nutrition, ADM, Pfizer, Abbott Laboratories, Bayer, Glanbia, Nature’s Sunshine Products
January 24, 2022
Via
AB Newswire
Pfizer and OPKO Provide Update on the Biologics License Application for Somatrogon for Pediatric Growth Hormone Deficiency
January 21, 2022
From
Pfizer Inc.
Via
Business Wire
< Previous
1
2
...
19
20
21
22
23
24
25
26
27
...
33
34
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.